Amylin, food intake, and obesity - PubMed (original) (raw)
Review
. 2002 Oct;10(10):1087-91.
doi: 10.1038/oby.2002.147.
Affiliations
- PMID: 12376591
- DOI: 10.1038/oby.2002.147
Free article
Review
Amylin, food intake, and obesity
Tarek K Reda et al. Obes Res. 2002 Oct.
Free article
Abstract
Amylin, also known as islet amyloid polypeptide, identified in 1987, is a naturally occurring hormone, released by the beta cells of the pancreas and consists of 37 amino acids. Amylin seems to decrease food intake through both central and peripheral mechanisms and indirectly by slowing gastric emptying. The mean basal amylin concentration is higher in obese than in lean human subjects. The amylin response to oral glucose is also greater in obese subjects, whether or not they have impaired glucose tolerance. The elevated amylin levels in obesity may lead to down-regulation of amylin receptors and lessen the impact of postprandial amylin secretion on satiety and gastric emptying. Amylin administration may overcome resistance at target tissues, delay gastric emptying, and have potential for inducing weight loss in obese individuals.
Similar articles
- Amylinergic control of food intake.
Lutz TA. Lutz TA. Physiol Behav. 2006 Nov 30;89(4):465-71. doi: 10.1016/j.physbeh.2006.04.001. Epub 2006 May 11. Physiol Behav. 2006. PMID: 16697020 Review. - Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187.
Gedulin BR, Jodka CM, Herrmann K, Young AA. Gedulin BR, et al. Regul Pept. 2006 Dec 10;137(3):121-7. doi: 10.1016/j.regpep.2006.06.004. Epub 2006 Aug 17. Regul Pept. 2006. PMID: 16914214 - Inhibition of gastric emptying.
Young A. Young A. Adv Pharmacol. 2005;52:99-121. doi: 10.1016/S1054-3589(05)52006-4. Adv Pharmacol. 2005. PMID: 16492543 Review. - Control of food intake and energy expenditure by amylin-therapeutic implications.
Lutz TA. Lutz TA. Int J Obes (Lond). 2009 Apr;33 Suppl 1:S24-7. doi: 10.1038/ijo.2009.13. Int J Obes (Lond). 2009. PMID: 19363503 Review. - Inhibition of food intake.
Young A. Young A. Adv Pharmacol. 2005;52:79-98. doi: 10.1016/S1054-3589(05)52005-2. Adv Pharmacol. 2005. PMID: 16492542 Review.
Cited by
- The role of the disulfide bond in the interaction of islet amyloid polypeptide with membranes.
Khemtémourian L, Engel MF, Kruijtzer JA, Höppener JW, Liskamp RM, Killian JA. Khemtémourian L, et al. Eur Biophys J. 2010 Aug;39(9):1359-64. doi: 10.1007/s00249-009-0572-4. Epub 2010 Jan 6. Eur Biophys J. 2010. PMID: 20052582 Free PMC article. - Hormonal and dietary characteristics in obese human subjects with and without food addiction.
Pedram P, Sun G. Pedram P, et al. Nutrients. 2014 Dec 31;7(1):223-38. doi: 10.3390/nu7010223. Nutrients. 2014. PMID: 25558907 Free PMC article. - Hallmarks of the metabolic secretome.
Reghupaty SC, Dall NR, Svensson KJ. Reghupaty SC, et al. Trends Endocrinol Metab. 2024 Jan;35(1):49-61. doi: 10.1016/j.tem.2023.09.006. Epub 2023 Oct 14. Trends Endocrinol Metab. 2024. PMID: 37845120 Free PMC article. Review. - Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.
Merlino DJ, Blomain ES, Aing AS, Waldman SA. Merlino DJ, et al. J Clin Med. 2014 Jul 15;3(3):763-94. doi: 10.3390/jcm3030763. J Clin Med. 2014. PMID: 26237477 Free PMC article. Review. - Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension.
Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Westgate CSJ, et al. J Headache Pain. 2021 Oct 10;22(1):123. doi: 10.1186/s10194-021-01337-0. J Headache Pain. 2021. PMID: 34629054 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical